Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Recombinant Adeno-Associated Virus Serotype 6 (rAAV6) Potently and Preferentially Transduces Rat Astrocytes In vitro and In vivo.

Schober AL, Gagarkin DA, Chen Y, Gao G, Jacobson L, Mongin AA.

Front Cell Neurosci. 2016 Nov 11;10:262.

2.

Determination of Anti-Adeno-Associated Viral Vector Neutralizing Antibodies in Patients With Heart Failure in the Cardiovascular Foundation of Colombia (ANVIAS): Study Protocol.

Rincon MY, Prada CE, Lopez M, Castillo V, Echeverria LE, Serrano N.

JMIR Res Protoc. 2016 Jun 9;5(2):e102. doi: 10.2196/resprot.5535.

3.

Characterization of the Adeno-Associated Virus 1 and 6 Sialic Acid Binding Site.

Huang LY, Patel A, Ng R, Miller EB, Halder S, McKenna R, Asokan A, Agbandje-McKenna M.

J Virol. 2016 May 12;90(11):5219-30. doi: 10.1128/JVI.00161-16.

4.

Gene therapy for cardiovascular disease: advances in vector development, targeting, and delivery for clinical translation.

Rincon MY, VandenDriessche T, Chuah MK.

Cardiovasc Res. 2015 Oct 1;108(1):4-20. doi: 10.1093/cvr/cvv205. Review.

5.

Adeno-associated viral (AAV) vectors do not efficiently target muscle satellite cells.

Arnett AL, Konieczny P, Ramos JN, Hall J, Odom G, Yablonka-Reuveni Z, Chamberlain JR, Chamberlain JS.

Mol Ther Methods Clin Dev. 2014;1. pii: 14038.

6.

Gene therapy for neurologic manifestations of mucopolysaccharidoses.

Wolf DA, Banerjee S, Hackett PB, Whitley CB, McIvor RS, Low WC.

Expert Opin Drug Deliv. 2015 Feb;12(2):283-96. doi: 10.1517/17425247.2015.966682. Review.

7.

Adeno-associated virus serotype 1 (AAV1)- and AAV5-antibody complex structures reveal evolutionary commonalities in parvovirus antigenic reactivity.

Tseng YS, Gurda BL, Chipman P, McKenna R, Afione S, Chiorini JA, Muzyczka N, Olson NH, Baker TS, Kleinschmidt J, Agbandje-McKenna M.

J Virol. 2015 Feb;89(3):1794-808. doi: 10.1128/JVI.02710-14.

8.

Adrenal adrenoceptors in heart failure.

de Lucia C, Femminella GD, Gambino G, Pagano G, Allocca E, Rengo C, Silvestri C, Leosco D, Ferrara N, Rengo G.

Front Physiol. 2014 Jul 7;5:246. doi: 10.3389/fphys.2014.00246. Review.

9.

GRK2 in the heart: a GPCR kinase and beyond.

Huang ZM, Gao E, Chuprun JK, Koch WJ.

Antioxid Redox Signal. 2014 Nov 10;21(14):2032-43. doi: 10.1089/ars.2014.5876. Review.

10.

Neuro-hormonal effects of physical activity in the elderly.

Femminella GD, de Lucia C, Iacotucci P, Formisano R, Petraglia L, Allocca E, Ratto E, D'Amico L, Rengo C, Pagano G, Bonaduce D, Rengo G, Ferrara N.

Front Physiol. 2013 Dec 20;4:378. doi: 10.3389/fphys.2013.00378. Review.

11.

An emerging adeno-associated viral vector pipeline for cardiac gene therapy.

Asokan A, Samulski RJ.

Hum Gene Ther. 2013 Nov;24(11):906-13. doi: 10.1089/hum.2013.2515. Review.

12.

Comparative analysis of adeno-associated virus capsid stability and dynamics.

Rayaprolu V, Kruse S, Kant R, Venkatakrishnan B, Movahed N, Brooke D, Lins B, Bennett A, Potter T, McKenna R, Agbandje-McKenna M, Bothner B.

J Virol. 2013 Dec;87(24):13150-60. doi: 10.1128/JVI.01415-13.

13.

╬▓1-adrenergic receptor and sphingosine-1-phosphate receptor 1 (S1PR1) reciprocal downregulation influences cardiac hypertrophic response and progression to heart failure: protective role of S1PR1 cardiac gene therapy.

Cannavo A, Rengo G, Liccardo D, Pagano G, Zincarelli C, De Angelis MC, Puglia R, Di Pietro E, Rabinowitz JE, Barone MV, Cirillo P, Trimarco B, Palmer TM, Ferrara N, Koch WJ, Leosco D, Rapacciuolo A.

Circulation. 2013 Oct 8;128(15):1612-22. doi: 10.1161/CIRCULATIONAHA.113.002659.

14.

C-reactive protein (CRP) is essential for efficient systemic transduction of recombinant adeno-associated virus vector 1 (rAAV-1) and rAAV-6 in mice.

Denard J, Marolleau B, Jenny C, Rao TN, Fehling HJ, Voit T, Svinartchouk F.

J Virol. 2013 Oct;87(19):10784-91. doi: 10.1128/JVI.01813-13.

15.

Improved adeno-associated virus (AAV) serotype 1 and 5 vectors for gene therapy.

Sen D, Balakrishnan B, Gabriel N, Agrawal P, Roshini V, Samuel R, Srivastava A, Jayandharan GR.

Sci Rep. 2013;3:1832. doi: 10.1038/srep01832.

16.

The potential of sarcospan in adhesion complex replacement therapeutics for the treatment of muscular dystrophy.

Marshall JL, Kwok Y, McMorran BJ, Baum LG, Crosbie-Watson RH.

FEBS J. 2013 Sep;280(17):4210-29. doi: 10.1111/febs.12295. Review.

17.

Targeted modifications in adeno-associated virus serotype 8 capsid improves its hepatic gene transfer efficiency in vivo.

Sen D, Gadkari RA, Sudha G, Gabriel N, Kumar YS, Selot R, Samuel R, Rajalingam S, Ramya V, Nair SC, Srinivasan N, Srivastava A, Jayandharan GR.

Hum Gene Ther Methods. 2013 Apr;24(2):104-16. doi: 10.1089/hgtb.2012.195.

18.

Minimally invasive closed-chest ultrasound-guided substance delivery into the pericardial space in mice.

Laakmann S, Fortm├╝ller L, Piccini I, Grote-Wessels S, Schmitz W, Breves G, Kirchhof P, Fabritz L.

Naunyn Schmiedebergs Arch Pharmacol. 2013 Mar;386(3):227-38. doi: 10.1007/s00210-012-0815-2.

19.

Gene transfer of heme oxygenase-1 using an adeno-associated virus serotype 6 vector prolongs cardiac allograft survival.

Evans JM, Navarro S, Doki T, Stewart JM, Mitsuhashi N, Kearns-Jonker M.

J Transplant. 2012;2012:740653. doi: 10.1155/2012/740653.

20.

Comparison of adeno-associated virus serotypes and delivery methods for cardiac gene transfer.

Fang H, Lai NC, Gao MH, Miyanohara A, Roth DM, Tang T, Hammond HK.

Hum Gene Ther Methods. 2012 Aug;23(4):234-41. doi: 10.1089/hgtb.2012.105.

Items per page

Supplemental Content

Support Center